ImClone Systems Inc (formerly IMCL)

[walk]

>If the "FLEX" data is what I hear it is (the rumor mill a-churnin') then Imclone is definitely getting lucrative share of lung cancer revenue.<

If the rumor mills a-churnin then I need some better contacts, because I haven't heard peep. Has anyone heard rumors on the FLEX results other than the UBS 1.3 month improvement in median OS.

If Erbitux in Lung garners lucrative market share, that could double sales.